Monsana
Monsana offers an AI-powered platform that connects eligible participants to relevant clinical trials throughout Europe.
Monsana offers an AI-powered platform that connects eligible participants to relevant clinical trials throughout Europe.
Monsana has raised $590k across 1 round. Its most recent round was a Pre-Seed of $590k in Sep 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Monsana is featured in
Similar companies
LaFraise develops artificial intelligence agents specifically for dentists to automate administrative processes.
Flyway Health is a healthtech company that offers brand-tailored AI agents for healthcare assistance.
OrahVision offers AI driven technology that allows people with low vision to read and interact with books, documents, and text naturally.
Yuanhe Vision is a high-tech enterprise specializing in AI-assisted ophthalmic diagnosis and optometry technology.
Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.
Textile Disassembly, Textile Recycling, Ecodesign, Circular Fashion, Design for Disassembly, Sustainable Fashion
Azumuta is an extremely comprehensive software solution that eradicates the need for physical documents in your factory. It covers digitalized work instructions, communication among frontline staff, data analysis, and IoT integration.
Partnership ecosystem platform
Powerhouse is an all-in-one property management platform built on Salesforce, streamlining the entire tenant journey and property operatiion
NietsCo provides professionals in the food and drink industry and individuals with quality products that are distilled in the same way as the original products, but completely alcohol-free.
Sunrise is striving to provide uncomplicated solutions to the millions of individuals who are struggling with sleep disorders. Our innovative 3-gram sensor has been devised to diagnose sleep disorders utilizing the highest quality gold standard methodology. The revolutionary technology allows for the assessment of brain activity during the night, providing unprecedented clinical results. The findings from studies indicate that Sunrise is as precise as in-lab sleep studies, but at a significantly lower cost. Sleep disorders affect one-third of the population, with sleep apnea being the most common, impacting almost one billion individuals globally. This ailment can cause unintentional harm to the body over time and unfortunately, goes unnoticed in 80% of cases. The introduction of a less complex, less costly, and less time-consuming diagnostic system would greatly benefit patients, healthcare professionals, and insurance providers.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.